Healthcare & Pharmaceuticals

From patient care to innovation, we're supporting the future of healthcare.

Overview

About 10% of Australia's GDP is spent on health. What are we getting for that? We get more than just a trip to the doctor, that's for sure. Modern healthcare encompasses extraordinary technical advances, commercialisation, patents, trade marks and other IP, and a highly regulated pharmaceutical sector.

There's innovation too in the way health services are developed and delivered, from research and health precincts through to healthcare infrastructure such as hospitals or aged care homes which integrate the latest technology with old-fashioned care and compassion. For those running a healthcare facility, there are also medical negligence and disciplinary proceedings. Underlying it all is the need to protect, manage and utilise vast amounts of sensitive data within strict privacy laws. And then there are the business issues: corporate governance, real estate acquisition, planning approvals, investments, and exit strategies.

We might not be able to solve physical headaches as easily as you can, but we know how to deal with the legal headaches – and even stop them from happening.

Our team to support you

Insights
Getting ready for Victoria's plans to enshrine WFH rights for all workers
27 Mar 2026 | Article
Read Insights
Workplace surveillance: A thing of the past? Not so fast
24 Mar 2026 | Article
Read Insights
The new Australian-European Union Free Trade Agreement: What it means for business
24 Mar 2026 | Article
Read Insights
Imperfect but not unreasonable: Supporting robust performance management and feedback processes
19 Mar 2026 | Article
Read Insights
No exemptions without proof: TGA pushes for enhanced powers to challenge use of the Annual Charge Exemption Scheme
16 Mar 2026 | Article
Read Insights
What directors and officers need to know about ASIC's Court result against Star's former board and executives
16 Mar 2026 | Article
Read Insights
Long time coming: NSW's new long service leave guidance is here
16 Mar 2026 | Article
Read Insights
ASIC's expectations for whistleblower programs: Critical findings from its recent whistleblower survey and next steps for Australian corporates in 2026
11 Mar 2026 | Article
Read Insights
Pharmaceutical patents: preliminary injunctions still available, despite complexities in undertaking as to damages calculations
6 Mar 2026 | Article
Read Insights
What insolvency practitioners and lenders need to know about the new merger control regime that commenced on 1 January 2026
4 Mar 2026 | Article
Read Insights
TGA's compliance principles for 2026 and 2027: A focus on proactive and risk-based enforcement in the digital landscape
6 Feb 2026 | Article
Read Insights
Delegates’ rights confirmed: the FWC expands powers of delegates in response to Full Federal Court decision
6 Feb 2026 | Article
Read Insights